UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma

Oral oncology, 2014-06, Vol.50 (6), p.527-538

2014

Volltextzugriff (PDF)

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Journal of clinical oncology, 2018-11, Vol.36 (31), p.JCO2018777847-3100

2018

Volltextzugriff (PDF)

A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients

Radiotherapy and oncology, 2012-09, Vol.104 (3), p.317-323

2012

Volltextzugriff (PDF)

Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation‐sensitive high resolution melting

International journal of cancer, 2015-02, Vol.136 (4), p.E127-E135

2015

Volltextzugriff (PDF)

Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6966-6975

2005

Volltextzugriff (PDF)

Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose–toxicity relationship

Radiotherapy and oncology, 2019-09, Vol.138, p.93-98

2019

Volltextzugriff (PDF)

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

European journal of cancer (1990), 2011-03, Vol.47 (5), p.656-666

2011

Volltextzugriff (PDF)

9314 POSTER The Clinical Outcome of Chinese Non-melanoma Skin Carcinoma Patients After Radiotherapy With Megavolage Electron

European journal of cancer (1990), 2011, Vol.47, p.S656-S656

2011

Volltextzugriff (PDF)

Individualized treatment in stage IVC nasopharyngeal carcinoma

Oral oncology, 2014-09, Vol.50 (9), p.791-797

2014

Volltextzugriff (PDF)

The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium

Cancer science, 2021-03, Vol.112 (3), p.1095-1104

2021

Volltextzugriff (PDF)

Cadherin- and Rigidity-Dependent Growth of Lung Cancer Cells in a Partially Confined Microenvironment

ACS biomaterials science & engineering, 2018-02, Vol.4 (2), p.446-455

2018

Volltextzugriff (PDF)

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality

International journal of radiation oncology, biology, physics, 2002-09, Vol.54 (1), p.182-190

2002

Volltextzugriff (PDF)

Proceedings of the 3rd Chinese University of Hong Kong (CUHK) Sarcoma Masterclass, September 21, 2019

Journal of Immunotherapy and Precision Oncology, 2020-05, Vol.3 (2), p.96-98

2020

Volltextzugriff (PDF)

Method of regulatory network that can explore protein regulations for disease classification

Artificial intelligence in medicine, 2010-02, Vol.48 (2), p.119-127

2010

Volltextzugriff (PDF)

Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10–29 years after initial remission

American journal of hematology, 2010-05, Vol.85 (5), p.362-363

2010

Volltextzugriff (PDF)

Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4

European journal of cancer (1990), 2022-11, Vol.175, p.236-245

2022

Volltextzugriff (PDF)

ProteinChip Array Profiling for Identification of Disease- and Chemotherapy-Associated Biomarkers of Nasopharyngeal Carcinoma

Clinical chemistry (Baltimore, Md.), 2007-02, Vol.53 (2), p.241-250

2007

Volltextzugriff (PDF)

First-line maintenance therapy with niraparib in advanced platinum-sensitive ovarian cancer: two ‘long responder’ case reports and review of the current literature

Journal of international medical research, 2023-09, Vol.51 (9), p.3000605231194881-3000605231194881

Ngan, Roger K. C.

2023

Volltextzugriff (PDF)

A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

Scientific reports, 2022-03, Vol.12 (1), p.3803-3803, Article 3803

2022

Volltextzugriff (PDF)

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

Oral oncology, 2018-02, Vol.77, p.16-21

2018

Volltextzugriff (PDF)

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study

Clinical cancer research, 2021-09, Vol.27 (17), p.4848-4858

2021

Volltextzugriff (PDF)

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Annals of oncology, 2023-03, Vol.34 (3), p.251-261

2023

Volltextzugriff (PDF)

Randomized Trial of Radiotherapy Plus Concurrent–Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma

JNCI : Journal of the National Cancer Institute, 2010-08, Vol.102 (15), p.1188-1198

2010

Volltextzugriff (PDF)

A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10‐year outcomes for efficacy and toxicity

Cancer, 2017-11, Vol.123 (21), p.4147-4157

2017

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(96)
Humans
(72)
Oncology
(44)
Female
(43)
Male
(35)
Adult
(33)
Middle Aged
(32)
Biological And Medical Sciences
(23)
Radiology, Nuclear Medicine & Medical Imaging
(23)
Medical Sciences
(22)
Nasopharyngeal Carcinoma
(22)
Aged
(21)
Chemotherapy
(20)
Treatment Outcome
(18)
Tumors
(18)
Nasopharyngeal Neoplasms - Pathology
(14)
Prognosis
(14)
Cancer
(13)
Nasopharyngeal Neoplasms - Drug Therapy
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients

Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation‐sensitive high resolution melting

Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose–toxicity relationship

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

9314 POSTER The Clinical Outcome of Chinese Non-melanoma Skin Carcinoma Patients After Radiotherapy With Megavolage Electron

Individualized treatment in stage IVC nasopharyngeal carcinoma

The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium

Cadherin- and Rigidity-Dependent Growth of Lung Cancer Cells in a Partially Confined Microenvironment

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality

Proceedings of the 3rd Chinese University of Hong Kong (CUHK) Sarcoma Masterclass, September 21, 2019

Method of regulatory network that can explore protein regulations for disease classification

Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10–29 years after initial remission

Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4

ProteinChip Array Profiling for Identification of Disease- and Chemotherapy-Associated Biomarkers of Nasopharyngeal Carcinoma

First-line maintenance therapy with niraparib in advanced platinum-sensitive ovarian cancer: two ‘long responder’ case reports and review of the current literature

A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Randomized Trial of Radiotherapy Plus Concurrent–Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma

A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10‐year outcomes for efficacy and toxicity

Suchergebnisse filtern